Skip to main content

Published locations for FDA alert: pembrolizumab ups mortality risk in multiple myeloma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA alert: pembrolizumab ups mortality risk in multiple myeloma

User login

  • Reset your password
  • /content/fda-alert-pembrolizumab-ups-mortality-risk-multiple-myeloma
  • /fedprac/article/145886/multiple-myeloma/fda-alert-pembrolizumab-ups-mortality-risk-multiple-myeloma
  • /hematologynews/article/145886/multiple-myeloma/fda-alert-pembrolizumab-ups-mortality-risk-multiple
  • /oncologypractice/article/145886/multiple-myeloma/fda-alert-pembrolizumab-ups-mortality-risk-multiple
  • /hematology-oncology/article/145886/multiple-myeloma/fda-alert-pembrolizumab-ups-mortality-risk